Pharma Industry
Industry: Email Alert RSS FeedSingulair allergy label expands.(Noted)
Pharmaceutical Processing, September, 2005
> Singulair allergy label expands: FDA approves broader allergy indication for Merck's Singulair for the "relief of symptoms of allergic rhinitis" in pediatric patients July 27. New indication for Singulair (montelukast sodium) is for treatment of "perennial allergic rhinitis in adults and pediatric patients 6 months of age and older." The therapy was previously approved for treatment of "seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older."
Brought to you by CBS MoneyWatch.com
- Best- and Worst-Paid College Degrees
- 6 Things You Should Never Do on Twitter or Facebook
- How Much Sleep Do You Really Need?
- 6 Big Myths about Gas Mileage
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Make running easier: with this unique 'pose running' technique, you'll learn to actually enjoy your fat-burning sessions
- 50 home remedies that work: these safe, fast, and effective fixes will relieve what ails you - Cover Story
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich


